SHIONOGI RECEIVES POSITIVE CHMP OPINION FOR FETCROJA® (CEFIDEROCOL) FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULT PATIENTS WITH LIMITED TREATMENT OPTIONS